Hana Pharm Co., Ltd.
293480.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
169
Cost of Revenue
63
Gross Profit
106
Gross Margin
62.7%
Operating Income
19
Operating Margin
11.2%
Net Income
16
Net Margin
9.4%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
25
EBITDA Margin
14.6%
2023
12/31/2023
Revenue
168
Cost of Revenue
64
Gross Profit
105
Gross Margin
62.2%
Operating Income
20
Operating Margin
12.0%
Net Income
17
Net Margin
9.9%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
26
EBITDA Margin
15.4%
2022
12/31/2022
Revenue
158
Cost of Revenue
60
Gross Profit
98
Gross Margin
62.2%
Operating Income
23
Operating Margin
14.8%
Net Income
18
Net Margin
11.5%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
28
EBITDA Margin
17.9%
2021
12/31/2021
Revenue
147
Cost of Revenue
49
Gross Profit
98
Gross Margin
66.6%
Operating Income
27
Operating Margin
18.3%
Net Income
21
Net Margin
14.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
31
EBITDA Margin
21.2%
2020
12/31/2020
Revenue
133
Cost of Revenue
47
Gross Profit
86
Gross Margin
64.3%
Operating Income
24
Operating Margin
17.9%
Net Income
11
Net Margin
8.4%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
25
EBITDA Margin
18.9%